RxDoctor Payments Data

Megan Maier, MD

Psychiatry · Grand Rapids, MINPI 1831683473

Payments from drug & device makers

$187in general payments, 2019–2025

Across 10 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$41
  • Vanda Pharmaceuticals Inc.$37
  • Neurocrine Biosciences, Inc.$27
  • E.r. Squibb & Sons, L.L.C.$20
  • Lundbeck LLC$19
  • Johnson & Johnson$15
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$187100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$187 in reported general payments places this provider in the 45th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$40,174
Medicare patients
109
Services billed
378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate11$93,263
VraylarCariprazine Hcl55$70,388
Invega SustennaPaliperidone Palmitate30$65,063
AustedoDeutetrabenazine15$63,350
Aripiprazole450$29,507
Lurasidone Hcl107$20,826
Chlorpromazine Hcl50$15,545
Risperidone572$10,380
Clozapine89$9,890
TrintellixVortioxetine Hydrobromide19$8,990
Quetiapine Fumarate301$6,676
Atomoxetine Hcl71$6,457
Clomipramine Hcl39$6,091
Clozapine OdtClozapine13$6,089
Sertraline Hcl438$5,833

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$27$93,26311 claims
Johnson & JohnsonInvega Sustenna$15$65,06330 claims
Teva Pharmaceuticals USA, Inc.Austedo$41$63,35015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →